Leap Therapeutics (LPTX) Competitor Comparison
We are evaluating the key criteria listed to compare Leap Therapeutics (LPTX) against its competitors in the Biotechnology industry.
Market Capitalization
277 / 368Gross Profits
0 / 278Total Revenue
0 / 300EBITDA
185 / 337Free Cashflow
211 / 352Quick Ratio
123 / 357Earnings per Share
133 / 359Dividend yield
0 / 6Total Cash
232 / 358Performance 3 years
281 / 368Performance 5 years
216 / 368Performance 10 years
298 / 368Linearity 3 years
243 / 368Linearity 5 years
58 / 368Linearity 10 years
211 / 368Total Rank
178 / 368Dividend Rank
185 / 368Valuation Rank
82 / 368Piotroski Rank
141 / 368Muliplier Rank
137 / 368Earnings per Share - LPTX ranking 133 / 359
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.